Joseph S McCracken
CIK 1632454 · last filed 2026-02-17
Joseph S McCracken is a corporate insider who has filed 43 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider exercised options covering $3.2K of SVRA on Feb 17, 2026. Across all open-market trades the lifetime net is +$531.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
4
43
$531.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SVRA | Director | 302,644 | $5.26 | $1.59M | $428.1K | 15 | 2026-02-17 |
| LUMOS PHARMA, INC. (LUMO) Delisted | Director | 0 | $4.34 | $0 | $103.8K | 9 | 2024-12-13 |
| Kindred Biosciences, Inc. (KIN) Delisted | Director | — | $9.25 | — | $0 | 6 | 2021-08-30 |
| Nexvet Biopharma plc (NVET) Delisted | Director | 12,800 | — | — | $0 | 12 | 2017-07-05 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-17 | SVRA | Exer (M) | +1,807 | $3.2K | EDGAR |
| 2025-12-11 | SVRA | Grant (A) | +40,000 | $0 | EDGAR |
| 2025-06-02 | SVRA | Buy (P) | +10,000 | $20.8K | EDGAR |
| 2024-12-16 | SVRA | Grant (A) | +40,000 | $0 | EDGAR |
| 2024-12-13 | LUMOS PHARMA, INC. (LUMO) Delisted | Disp (D) | −15,721 | $0 | EDGAR |
| 2024-11-20 | SVRA | Buy (P) | +20,000 | $59.1K | EDGAR |
| 2024-06-07 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | SVRA | Grant (A) | +22,500 | $0 | EDGAR |
| 2023-05-12 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-15 | SVRA | Grant (A) | — | $0 | EDGAR |